Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for Multiple Myeloma
Drug: Teclistamab
42 locations incl. Phoenix
Sponsor: European Myeloma Network B.V.
Sex: All·Age: 18+
Code: NCT05243797·Phase 3·Recruiting